Development of a joint set of database parameters for the EU-ROP and Fight Childhood Blindness! ROP Registries

Caroline Catt1,2, Johanna M Pfeil3, Daniel Barthelmes2,4

  • 1Department of Ophthalmology, The Children's Hospital at Westmead, Westmead, New South Wales, Australia carolinecatt@hotmail.com.

PubMed

Insights

A minimal dataset for retinopathy of prematurity (ROP) treatment is proposed to track outcomes. This standardized approach aims to improve patient care and enable consistent ROP research.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Clinical Data Management

Background:

  • The incidence of retinopathy of prematurity (ROP) is rising, with expanding treatment options lacking comprehensive safety data.
  • There is a need for standardized data collection to effectively monitor and compare ROP treatment outcomes.

Purpose of the Study:

  • To define a minimal, patient-centered dataset for ROP treatment.
  • To establish a feasible data set for clinical practice and collaborative outcome tracking.
  • To improve patient outcomes through standardized ROP treatment research.

Main Methods:

  • A multinational collaboration of clinicians and a patient representative was formed.
  • Expertise in ROP and registry development guided the data set creation.
  • Focus on real-world, patient-centered, minimal, and feasible parameters for routine clinical practice.

Main Results:

  • Recommended data points include patient demographics, comorbidities, ROP status, and treatment details.
  • Collection of ophthalmic and systemic complications, and short/long-term outcomes is advised.
  • Includes data on retreatment episodes and follow-up examinations for comprehensive tracking.

Conclusions:

  • The proposed parameters should be adopted in ROP registries and studies.
  • Standardization will reduce variability in reports and allow meaningful comparisons.
  • These parameters form the foundation for the EU-ROP and Fight Childhood Blindness! ROP Registries.
Abstract

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
884
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
595
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K